SCHEMBL2118993

SCHEMBL2118993

O=C1c2ccccc2OC(O)(c2ccccc2O)C1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNG2 P59768 1/20 0.37
GNB1 P62873 1/20 0.37
STK17B O94768 1/20 0.36
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPT P10636 3/20 0.35
TDP1 Q9NUW8 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 2/20 0.35
CYP3A4 P08684 2/20 0.35
ALOX15 P16050 2/20 0.35
PDK2 Q15119 1/20 0.35
ESR1 P03372 1/20 0.35
TP53 P04637 1/20 0.35
TYMS P04818 1/20 0.35
TSHR P16473 1/20 0.35
ESR2 Q92731 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3289417 0.80 CYP3A4 (0.42) STK17BMEN1KMT2AALDH1A1MAPT
SCHEMBL28320415 0.77 RET (0.41) STK17BMEN1KMT2AALDH1A1CYP3A4
SCHEMBL5830003 0.73 IDO1 (0.40) ALDH1A1CYP3A4ALOX15TSHRRET
SCHEMBL3197529 0.72 CYP19A1 (0.46) KMT2AALDH1A1MAPTTDP1SMN1; SMN2
SCHEMBL14336057 0.71 MAOA (0.35) MEN1KMT2ALMNACYP3A4PDK2
SCHEMBL17237773 0.71 RAD52 (0.42) STK17BMEN1KMT2AALDH1A1MAPT
SCHEMBL7049756 0.70 ALDH1A1 (0.42) GNG2GNB1MEN1KMT2AALDH1A1
SCHEMBL14336079 0.70 PTPN1 (0.38) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL2967628 0.69 OPRM1 (0.34) ALDH1A1MAPTCYP3A4ALOX15HSD17B10
SCHEMBL3289413 0.69 ATM (0.44) MEN1KMT2AALDH1A1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119320777-A Metabolite screening method for promoting expression of porcine intestinal defensin pBD1 and application thereof 浙江大学 2025-01-17 CN claimed
US-20240301326-A1 CAGELESS SELF-ADHESIVE LAVATORY CLEANING COMPOSITION Reckitt Benckiser Health Limited (GB) 2024-09-12 US claimed
EP-4373906-A1 CAGELESS SELF-ADHESIVE LAVATORY CLEANING COMPOSITION Reckitt & Colman (Overseas) Hygiene Home Limited (GB) 2024-05-29 EP claimed
CN-117716012-A Cage-free self-adhesive toilet cleaning composition 雷克特和科尔曼(海外)家用卫生有限公司 2024-03-15 CN claimed
US-20230248755-A1 COMPOSITIONS FOR IMPROVING JOINT HEALTH BioRelief, LLC (US) 2023-08-10 US claimed
CN-115787325-A Polyester low-temperature dyeing accelerant and preparation method thereof 太仓宝霓实业有限公司 2023-03-14 CN claimed
WO-2023002214-A1 CAGELESS SELF-ADHESIVE LAVATORY CLEANING COMPOSITION Reckitt & Colman (Overseas) Hygiene Home Limited (GB) 2023-01-26 WO claimed
US-20210060048-A1 COMPOSITIONS FOR IMPROVING JOINT HEALTH BIORELIEF LLC (US) 2021-03-04 US claimed
WO-2013079187-A9 TASTE-MASKING COMPOSITIONS, SWEETENER COMPOSITIONS AND CONSUMABLE PRODUCT COMPOSITIONS CONTAINING THE SAME NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) 2016-04-14 WO claimed
EP-2875359-A2 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME DISORDERS Charles R Drew University of Medicine and Science (US) 2015-05-27 EP claimed
US-20130136839-A1 Taste-Masking Compositions, Sweetener Compositions and Consumable Product Compositions Containing the Same NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) 2013-05-30 US claimed
US-20130136836-A1 Taste-Masking Compositions, Sweetener Compositions and Consumable Product Compositions Containing the Same NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) 2013-05-30 US claimed
EP-1067913-B1 COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS BIORESPONSE LLC (US) 2012-08-29 EP claimed
CN-1990482-B Flavanonol compounds and their production method and use ZHEJIANG HISUN PHARM CO LTD 2010-12-08 CN claimed
EP-1067913-A4 COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS BIORESPONSE LLC (US) 2009-03-11 EP claimed
CN-1990482-A Flavanonol compounds and their production method and use ZHEJIANG HISUN NATURELITE PHAR (CN) 2007-07-04 CN claimed
US-20040180800-A1 Cleaning and protecting composition with antioxidant and UV light resistance and method of use HOMECARE LABS, INC. 2004-09-16 US claimed
EP-1067913-A1 COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS Bioresponse, L.L.C. (US) 2001-01-17 EP claimed
WO-1999049851-A1 COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS BIORESPONSE, L.L.C. (US) 1999-10-07 WO claimed
EP-0245931-A2 Nodulation inducing factors LUBRIZOL GENETICS INC. (US) 1987-11-19 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210060048-A1 COMPOSITIONS FOR IMPROVING JOINT HEALTH TRPV1, CALCB, TRPV2 GNG2 109/4885GNB1 530/4885STK17B 4590/4885
US-20230248755-A1 COMPOSITIONS FOR IMPROVING JOINT HEALTH TRPV1, CALCB, TRPV2 GNG2 109/4885GNB1 530/4885STK17B 4590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.